Posts filtered by tags: Maria Elena Bottazzi[x]


 

Pfizer just asked the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people

The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore receiving an injection. University of Maryland School of Medicine/AP Photo Pfizer and BioNTech requested that the US Food and Drug Administration review their coronavirus vaccine for emergency authorization, they announced Friday. The vaccine was found to be 95% effective at preventing COVID-19 in a late-stage trial. The FDA has said it might ...
Tags: News, US, Trends, Healthcare, Fda, Pfizer, Baltimore, Centers For Disease Control And Prevention, Reuters, US Food and Drug Administration, Baylor College of Medicine, University of Maryland School of Medicine, Moderna, Andrew Dunn, BioNtech, Albert Bourla


Pfizer is about to ask the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people

The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. University of Maryland School of Medicine/AP Photo Pfizer and BioNTech are about to request that the US Food and Drug Administration review their coronavirus vaccine for emergency authorization. The vaccine was 95% effective at preventing COVID-19 in a late-stage trial. The FDA has said it might take weeks to review the...
Tags: News, US, Trends, Healthcare, Fda, Pfizer, Baltimore, Centers For Disease Control And Prevention, Reuters, US Food and Drug Administration, Baylor College of Medicine, University of Maryland School of Medicine, Moderna, Andrew Dunn, BioNtech, Allana Akhtar


When can I get a coronavirus vaccine?

Jakub Porzycki/NurPhoto via Getty Images Both Moderna and Pfizer have recently delivered promising news that their coronavirus vaccines are highly effective, in large, diverse human trials. But that doesn't mean you're going to be able to get a shot before the end of 2020.  In all likelihood, the first coronavirus vaccines will begin rolling out to frontline workers and vulnerable populations in the last days of 2020, or possibly early 2021. By Memorial Day in late May, it's possible that...
Tags: Science, News, Cdc, White House, US, Trends, Public Health, South Africa, New York Times, Vaccination, Fda, Pfizer, Anthony Fauci, Istanbul, Soweto, Ankara Turkey


7 unanswered questions about the coronavirus vaccines from Pfizer and Moderna

Xinhua/Gil Cohen Magen via Getty Images There are now two vaccine trials with promising results, but there are plenty of caveats to the good news. We still don't know whether the vaccine protects against asymptomatic cases or if it even lowers the risk of spreading COVID-19. The two companies behind the vaccines, Pfizer and Moderna, have yet to publish their vaccine data in medical journals, and both are pending approval by the FDA. Visit Business Insider's homepage for more stories. Two ...
Tags: Trends, Salmon, Poland, World Health Organization, Astrazeneca, Fda, Pfizer, Anthony Fauci, Wall Street Journal, Mayo Clinic, Johnson Johnson, Fauci, US Health and Human Services, Moderna, National Academies of Sciences, Stéphane Bancel


7 unanswered questions about Pfizer's promising coronavirus vaccine

Xinhua/Gil Cohen Magen via Getty Images The preliminary results of Pfizer's coronavirus vaccine trial are promising, but there are plenty of caveats to the good news. We still don't know whether the vaccine protects against asymptomatic cases or if it even lowers the risk of spreading COVID-19. Questions of who will have access to the shot and when depend on how Pfizer and US public health agencies allocate the vaccine. Complete data on the vaccine's effectiveness and safety won't be publ...
Tags: Africa, Nbc News, US, Trends, Salmon, Healthcare, Food And Drug Administration, Poland, World Health Organization, Fda, Pfizer, Anthony Fauci, Wall Street Journal, Mayo Clinic, Johnson Johnson, Asia Latin America


The Pfizer COVID-19 vaccine won't save Christmas, or even Easter and Passover, experts say

A health care worker injects a patient with a syringe of the phase 3 Pfizer and BioNTech vaccine trial in Turkey in October 2020. Dogukan Keskinkilic/Anadolu Agency via Getty Images Pfizer said in a press release that its experimental vaccine is 90% effective at preventing COVID-19, a promising step toward slowing the spread of the virus.  Still, it could be months before the vaccine is readily available to many people. The study is not over, it hasn't been reviewed by regulators, and supp...
Tags: Trends, Turkey, Pfizer, Anthony Fauci, Drexel University, Baylor College of Medicine, McClure, Fauci, Robert Wood Johnson Foundation, Richard Besser, BioNtech, Hilary Brueck, Maria Elena Bottazzi, Gabby Landsverk, Getty Images Pfizer, Dogukan Keskinkilic Anadolu Agency


Pfizer's promising COVID-19 vaccine won't save Christmas, or even Easter and Passover, experts say

A health care worker injects a patient with a syringe of the phase 3 Pfizer and BioNTech vaccine trial in Turkey in October 2020. Dogukan Keskinkilic/Anadolu Agency via Getty Images Pfizer said in a press release that its experimental vaccine is 90% effective at preventing COVID-19, a promising step toward slowing the spread of the virus.  Still, it could be months before the vaccine is readily available to many people. The study is not over, it hasn't been reviewed by regulators, and supp...
Tags: Trends, Turkey, Pfizer, Anthony Fauci, Drexel University, Baylor College of Medicine, McClure, Fauci, Robert Wood Johnson Foundation, Richard Besser, BioNtech, Hilary Brueck, Maria Elena Bottazzi, Gabby Landsverk, Getty Images Pfizer, Dogukan Keskinkilic Anadolu Agency


We just got the world-changing news that Pfizer's coronavirus vaccine works. Here's what you need to know and why you shouldn't throw your mask away just yet.

A 16-year-old participates in Pfizer's clinical trial to test its coronavirus vaccine candidate. She was the first adolescent patient at Cincinnati Children’s Hospital to enroll in the study. Cincinnati Children’s Hospital Pfizer just said that its experimental coronavirus vaccine helps prevent COVID-19.  It's a big victory in the fight against the pandemic. Still, the data haven't yet been published in a peer-reviewed journal, and the vaccine has not yet been reviewed by regulators. S...
Tags: Politics, News, US, Trends, Healthcare, Medicare, Fda, Pfizer, Vaccine, Getty, Don, Johnson Johnson, Moderna, Cincinnati Children 's Hospital, BioNtech, Coronavirus


The Trump administration's race to get a coronavirus vaccine means Americans may not know which treatment works best

Dr. Rhonda Flores looks at protein samples at Novavax labs, one of the labs developing a vaccine for the coronavirus, in Gaithersburg, Maryland on March 20, 2020. Andrew Caballero-Reynolds/AFP The first coronavirus vaccines in the US may only be "moderately effective" and won't reduce the need to wear masks, in part due to the country's haste to develop a treatment, The New York Times reported. Instead of vetting different companies' vaccines against each other, a process called the "maste...
Tags: US, Trends, New York Times, Healthcare, Astrazeneca, The New York Times, Vaccine, Donald Trump, Business Insider, Trump, Baylor College of Medicine, Fauci, Novavax, Gaithersburg Maryland, Andrew Caballero Reynolds, Andrew Dunn


SIGN UP: Learn the latest on the road ahead for a COVID-19 vaccine at our live event on Monday

Courtesy of Art Caplan; Courtesy of William Haseltine; Courtesy of Maria Elena Bottazzi; Samantha Lee/Business Insider Subscribe to Business Insider to RSVP to our live event. Already a subscriber? You can sign up here. Coronavirus vaccine research is moving fast. Keep up on the latest — and know what's coming ahead — with Business Insider's latest live webinar on October 5th at 2:00 p.m. ET. Several candidates are now in the final stage of clinical testing, with the leading vaccines lik...
Tags: Science, Trends, Healthcare, Webinar, Dunn, Live Events, William Haseltine, Samantha Lee, ACCESS Health International, Andrew Dunn, Maria Elena Bottazzi, BI Graphics, Courtesy of Maria Elena Bottazzi, Art Caplan


SIGN UP: Learn the latest on the road ahead for a COVID-19 vaccine at our live event on October 5

Courtesy of Art Kaplan; Courtesy of William Haseltine; Courtesy of Maria Elena Bottazzi; Samantha Lee/Business Insider Subscribe to Business Insider to RSVP to our live event. Already a subscriber? You can sign up here. Coronavirus vaccine research is moving fast. Keep up on the latest — and know what's coming ahead — with Business Insider's latest live webinar on October 5th at 2:00 p.m. ET. Several candidates are now in the final stage of clinical testing, with the leading vaccines lik...
Tags: Science, Trends, Healthcare, Webinar, Dunn, Live Events, William Haseltine, Samantha Lee, ACCESS Health International, Andrew Dunn, Maria Elena Bottazzi, BI Graphics, Art Kaplan, Courtesy of Maria Elena Bottazzi


SIGN UP: Learn the latest on the road ahead for a COVID-19 shot at our live event

Courtesy of Art Kaplan; Courtesy of William Haseltine; Courtesy of Maria Elena Bottazzi; Samantha Lee/Business Insider Subscribe to Business Insider to RSVP to our live event. Already a subscriber? You can sign up here. Coronavirus vaccine research is moving fast. Keep up on the latest — and know what's coming ahead — with Business Insider's latest live webinar on October 5th at 2:00 p.m. ET. Several candidates are now in the final stage of clinical testing, with the leading vaccines lik...
Tags: Science, Trends, Healthcare, Webinar, Dunn, Live Events, William Haseltine, Samantha Lee, ACCESS Health International, Andrew Dunn, Maria Elena Bottazzi, BI Graphics, Art Kaplan, Courtesy of Maria Elena Bottazzi


J&J has started its late-stage coronavirus vaccine trial

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,Today in healthcare news: GoodRx is making its stock-market debut after pricing shares at $33 apiece just after midnight. At that price, the company is valued at $12.7 billion. What a time to be in the digital health/online prescription drug coupon business. Also: Johnso...
Tags: US, Trends, United States, Chile, National Institutes of Health, Fda, Donald Trump, Anthony Fauci, Afp, Johnson Johnson, Johns Hopkins University, Steve Parsons, Brooklyn Hospital Center, Oscar Health, Paul Stoffels, William Haseltine


Fauci: We'll likely be wearing masks for most of 2021, even after a vaccine rolls out

Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci watches as Vice President Mike Pence speaks after leading a White House Coronavirus Task Force briefing at the Department of Health and Human Services on June 26, 2020 in Washington, DC. Joshua Roberts/Getty Images Dr. Anthony Fauci says a vaccine alone is not going to "get us to the point where we want to be, by the end of 2021." We'll need to vaccinate, social distance, continue hand hygiene, and use ...
Tags: Science, Washington, US, Trends, Public Health, Washington Dc, Philadelphia, Vaccine, Seattle, Anthony Fauci, Mike Pence, Baylor College of Medicine, Department of Health and Human Services, Children s Hospital, Fauci, Paul Offit


Fauci says planning weddings and parties for 2022 is 'a pretty good bet'

Drew Angerer/Getty Images; Samantha Lee/Business Insider Dr. Anthony Fauci says, if you're delaying a big gathering like a wedding until 2022, "that's quite reasonable." It may take until late 2021 for every American who wants to get vaccinated against the coronavirus to get their shots. But Fauci also said that, ultimately, it's up to us to stop the virus together. "It's all going to depend on the level of infection in the community," he said, a metric that will depend on how many people...
Tags: Health, Science, Milan, News, Trends, Ap, Public Health, Weddings, Vaccines, Anthony Fauci, Centers For Disease Control And Prevention, Milan Italy, Baylor College of Medicine, Fauci, Samantha Lee, Robert Redfield


CDC director Robert Redfield said face masks may be more effective than a vaccine in preventing individual coronavirus infections

Robert Redfield, director of the Centers for Disease Control and Prevention (CDC), wears a mask during a House subcommittee hearing on July 31, 2020 in Washington, DC. Erin Scott-Pool/Getty Images CDC director Robert Redfield said on Wednesday that wearing a mask might be "more guaranteed" to protect an individual from the coronavirus than a vaccine.  Redfield's comments came in response to a Senator's question about whether President Trump is undercutting coronavirus-prevention efforts by...
Tags: Cdc, Washington, Senate, White House, US, Trends, Missouri, Washington Dc, House, Fda, Donald Trump, Anthony Fauci, Centers For Disease Control And Prevention, Trump, Robert, The Boston Globe


CDC director Robert Redfield suggests face masks may be more effective than a vaccine in preventing individual coronavirus infections

Robert Redfield, director of the Centers for Disease Control and Prevention (CDC), wears a mask during a House subcommittee hearing on July 31, 2020 in Washington, DC. Erin Scott-Pool/Getty Images CDC director Robert Redfield said on Wednesday that wearing a mask might be "more guaranteed" to protect an individual from the coronavirus than a vaccine.  Redfield's comments came in response to a Senator's question about whether President Trump is undercutting coronavirus-prevention efforts by...
Tags: Cdc, Washington, Senate, White House, US, Trends, Missouri, Washington Dc, House, Fda, Donald Trump, Anthony Fauci, Centers For Disease Control And Prevention, Trump, The Boston Globe, Baylor College of Medicine


Even if there's a coronavirus vaccine next year, don't expect to throw away your mask and stop social distancing, a top vaccine developer says

"The moment you get a vaccine doesn't mean you're going to put your mask in the trash," Baylor vaccine researcher Maria Elena Bottazzi told BI.
Tags: News, Baylor, Maria Elena Bottazzi


A vaccine for Wuhan coronavirus could take years to develop, based on our experience trying to fight Zika and Ebola

Several biotech companies have rolled out plans to develop vaccines to protect people against the Wuhan, China coronavirus, with support from global health groups and the US government. But vaccine development has historically been an arduous, multi-year process. None of the biotechs provided expected timelines to get their vaccines on the market. Previous infectious disease outbreaks, including for the Ebola and Zika viruses, show the challenges likely to face experimental vaccines for this v...
Tags: US, Trends, Middle East, Anthony Fauci, Wuhan, Zika, Sars, Fauci, Cambridge Massachusetts, Wuhan China, The National Institutes of Health, Moderna, Inovio, Stéphane Bancel, Christopher Raymond, Moderna Novavax